Next generation of steady-state or perfusion cultivating Single-Use-Bioreactors for continuous expression of proteins.
- CellMembra integrate Perfusion-Single-Use-Bioreactor come with the One-way Single-Use-Pump and Single-Use-Sensor's and single-use Hollow-Filter-Module operating at Pulsating-Tangential-Flow principle for cell retention. So far available in 0,5 and 3,2 litre Vessel Volume operating at +100 mio/cells/ml.
- CellRetention integrate Perfusion-Single-Use-Bioreactor come with the Alternating-Single-Use-Exchanger and Single-Use-Sensor's and single-use Hollow-Filter-Module operating at Pulsating-Tangential-Flow principle for cell retention. Available from 100 ml to 2,000 ml Working Volume operating at +100 mio/cells/ml.
- CellCore is a concept platform including scaffold or macro-beads for harbouring either suspension or adherent mammalian cells easily at 150 mio/cells/ml at steady-state conditions. CellCore is scalable from 15 ml to 15.000 ml all sizes as desktop models.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Nørrelundvej 10, Herlev,capital Region 2730,denmark
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- perfusecell.com
- HQ
- Herlev, Capital Region
Perfusecell A/s Questions
Perfusecell A/S's website is perfusecell.com
Perfusecell A/S's LinkedIn profile is https://dk.linkedin.com/company/perfusecell
Perfusecell A/S has
2 employees.
View email and phone details for 2
employees at Perfusecell A/S.
Perfusecell A/S's industry is
Biotechnology Research
Perfusecell A/S's top competitors are
Finesse Solutions,
Into Bioprocess,
Rowemed Ag - Medical 4 Life,
Cercell A/s,
Artel,
Zellwerk Gmbh & Co. Kg,
Stobbe Group - Cercell - Perfusecell - Cronus-Pcs,
Inocells B.v.,
Perfuse,
Thermogenesis Holdings, Inc..
Perfusecell A/S's categories are Biotechnology Research
Perfusecell A/S's founding year is 2008
